7. Zelnorm - Top 10 Warnings and Recalls

Drug: Zelnorm

2006 sales: $561 million

Manufacturer: Novartis

Safety concern: Recall; heart risks

Related Articles:
> FDA allows limited Zelnorm use. Report
> Novartis shares slide after Zelnorm gets yanked. Report
> EMEA committee rejects Novartis' Zelnorm. Report

7. Zelnorm - Top 10 Warnings and Recalls
Read more on

Suggested Articles

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

Pfizer struck a deal to produce Gilead Sciences' remdesivir, which has been running short at some hard-hit U.S. hospitals.